Existing users please login

 

Home / Markets

Wyeth in Talks to Buy Crucell

 
Associated Press
     

    NEW YORK--Dutch vaccine maker Crucell (CRXL) says it is in acquisition talks with drugmaker Wyeth (WYE). Crucell NV says the talks are at preliminary stages.

    The statement comes shortly after a Wall Street Journal report saying Wyeth was in talks to buy Crucell for up to $1.35 billion.

    A spokesman for Madison, New Jersey-based Wyeth says the company does not comment on market speculation.
    The report, published on the newspaper's Web site Wednesday and attributed to unnamed sources, comes hours after Wyeth Chief Executive and Chairman Bernard Poussot told analysts at an investment conference that he believes "the only way forward for the pharmaceutical industry is to get into biotechnology."

     

    Fox Business Video